Table 1

Demographic characteristics of unmatched individuals vaccinated versus unvaccinated against HZ

Any HZ vaccine (n=45 960)No HZ vaccine (n=3 363 873)SMD
Age63.46±7.7663.30±9.300.019
Sex
 Female22 594 (49.16)1 599 758 (47.56)0.032
 Male20 606 (44.84)1 656 250 (49.24)0.088
Race
 White27 076 (58.91)1 950 119 (57.97)0.019
 Black or African American7218 (15.71)563 189 (16.74)0.028
 Asian2928 (6.37)142 295 (4.23)0.096
Socio-economic status
Persons with potential health hazards related to socio-economic and psychosocial circumstances513 (1.12)8856 (0.26)0.103
Comorbidities
 Hypertensive diseases25 190 (54.81)463 468 (13.78)0.959
 Overweight and obesity8980 (19.54)149 819 (4.45)0.477
 Other forms of heart disease5651 (12.30)205 284 (6.10)0.216
 Chronic kidney disease3257 (7.09)89 980 (2.68)0.206
 Neoplasms3815 (8.30)83 995 (2.50)0.259
 Nicotine dependence2673 (5.82)67 311 (2.00)0.198
 Hypertensive chronic kidney disease1175 (2.56)26 124 (0.78)0.139
 Alcohol-related disorders734 (1.60)18 739 (0.56)0.101
 Fibrosis and cirrhosis of liver438 (0.95)19 169 (0.57)0.044
 Unspecified dementia235 (0.51)7108 (0.21)0.05
 Alcoholic liver disease189 (0.41)6594 (0.20)0.039
 Alzheimer’s disease144 (0.31)3447 (0.10)0.046
 Dementia in other diseases classified elsewhere161 (0.35)3858 (0.12)0.049
 Hepatic failure, not elsewhere classified140 (0.31)5878 (0.18)0.027
 Chronic hepatitis, not elsewhere classified21 (0.05)730 (0.02)0.013
 Vascular dementia61 (0.13)1394 (0.04)0.031
 Rheumatoid arthritis with rheumatoid factor22 (0.05)1081 (0.03)0.008
  • Age is presented as mean±SD, while sex, race, socio-economic status and comorbidities are presented as sample numbers and percentages.

  • Any HZ vaccine, Shingrix or Zostavax; HZ, herpes zoster; SMD, standardised mean difference.